Oracle (ORCL) Sees Q4 Sales Down 2% to Up 2%
Tweet
Share
E-mailGet Alerts ORCL Hot Sheet
Price: $147.39 +3.74%
Revenue Growth %: +28.1%
Financial Fact:
Operating income: 2.64B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Revenue Growth %: +28.1%
Financial Fact:
Operating income: 2.64B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Oracle (Nasdaq: ORCL) sees Q4 non-GAAP sales down 2 percent to up 2 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) October 175 calls active as share price up 3.6%
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
